Clinical Trial Results: What the Evidence Shows About Weight Loss The STEP clinical trials, which evaluated semaglutide for weight management, followed over 4,500 patients for 68 weeks and showed average weight losses of 1015% in standard-dose groups and up to 22% in higher-dose populations
The two are deeply intertwined
If youre struggling with weight management, we offer a comprehensive approach that includes FDA-approved medications such as Semaglutide, Zepbound, and Wegovy, alongside lifestyle changes to help you achieve sustainable weight loss and improve your overall well-being
It really does feel like you have a personal coach helping you out while you exercise, writes one reviewer
It does not automatically disqualify a provider, but it is part of the context patients should understand before assuming that an online GLP-1 intake equals a full obesity-medicine workup